Peer-reviewed journal articles (260)
119.
Saussez, S., Lorfevre, F., Lequeux, T., Laurent, G., Chantrain, G., Vertongen, F., Toubeau, G., Decaestecker, C., & Kiss, R. (2008). The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy. Oral oncology, 44(1), 86-93. doi:10.1016/j.oraloncology.2006.12.014120.
Saussez, S., Decaestecker, C., Lorfevre, F., Cucu, D.-R., Mortuaire, G., Chevalier, D., Wacreniez, A., Kaltner, H., André, S., Toubeau, G., Camby, I., Gabius, H.-J., & Kiss, R. (2007). High level of galectin-1 expression is a negative prognostic predictor of recurrence in laryngeal squamous cell carcinomas. International journal of oncology, 30(5), 1109-1117.121.
Megalizzi, V., Mathieu, V., Mijatovic, T., Gailly, P., Debeir, O., De Nève, N., Van Damme, M., Bontempi, G., Haibe-Kains, B., Decaestecker, C., Kondo, Y., Kiss, R., & Lefranc, F. (2007). 4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugs. Neoplasia (New York, N.Y.), 9(5), 358-369.123.
Sadeghi-Meibodi, N., Salmon, I., Decaestecker, C., Levivier, M., Metens, T., Wikler, D., Denolin, V., Rorive, S., Massager, N., Balériaux, D., & Goldman, S. (2007). Stereotactic comparison among cerebral blood volume, methionine uptake, and histopathology in brain glioma. American journal of neuroradiology, 28(3), 455-461.124.
Mijatovic, T., Gailly, P., Mathieu, V., De Nève, N., Yeaton, P., Kiss, R., & Decaestecker, C. (2007). Neurotensin is a versatile modulator of in vitro human pancreatic ductal adenocarcinoma cell (PDAC) migration. Cellular oncology, 29(4), 315-326.125.
Servotte, S., Camby, I., Debeir, O., Deroanne, C., Lambert, C. A., Lapière, C. M., Kiss, R., Nusgens, B., & Decaestecker, C. (2006). The in vitro influences of neurotensin on the motility characteristics of human U373 glioblastoma cells. Neuropathology and applied neurobiology, 32(6), 575-584. doi:10.1111/j.1365-2990.2006.00760.x126.
Rorive, S., Maris, C., Debeir, O., Sandras, F., Vidaud, M., Bièche, I., Salmon, I., & Decaestecker, C. (2006). Exploring the distinctive biological characteristics of pilocytic and low-grade diffuse astrocytomas using microarray gene expression profiles. Journal of neuropathology and experimental neurology, 65(8), 794-807. doi:10.1097/01.jnen.0000228203.12292.a1127.
Saussez, S., Cucu, D.-R., Decaestecker, C., Chevalier, D., Kaltner, H., André, S., Wacreniez, A., Toubeau, G., Camby, I., Gabius, H.-J., & Kiss, R. (2006). Galectin 7 (p53-induced gene 1): a new prognostic predictor of recurrence and survival in stage IV hypopharyngeal cancer. Annals of surgical oncology, 13(7), 999-1009. doi:10.1245/ASO.2006.08.033128.
Ghanooni, R., Decaestecker, C., Simon, P., Gabius, H.-J., Hassid, S., & Choufani, G. (2006). Characterization of patterns of expression of protein kinase C-alpha, -delta, -eta, -gamma and -zeta and their correlations to p53, galectin-3, the retinoic acid receptor-beta and the macrophage migration inhibitory factor (MIF) in human cholesteatomas. Hearing research, 214(1-2), 7-16. doi:10.1016/j.heares.2006.01.013129.
Hayot, C., Debeir, O., Van Ham, P., Van Damme, M., Kiss, R., & Decaestecker, C. (2006). Characterization of the activities of actin-affecting drugs on tumor cell migration. Toxicology and applied pharmacology, 211(1), 30-40. doi:10.1016/j.taap.2005.06.006130.
Dubois, F., Yourassowsky, C., Monnom, O., Legros, J. C., Debeir, O., Van Ham, P., Kiss, R., & Decaestecker, C. (2006). Digital holographic microscopy for the three-dimensional dynamic analysis of in vitro cancer cell migration. Journal of biomedical optics, 11(5), 054032. doi:10.1117/1.2357174